Announcements Trials
Browse Landscape

Status

Completed 9Unknown 8Recruiting 6Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 23Observational 6

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 518Breast Neoplasms 461Lung Neoplasms 256Prostatic Neoplasms 235Colorectal Neoplasms 218Carcinoma, Non-Small-Cell Lung 188Pancreatic Neoplasms 157Stomach Neoplasms 140Carcinoma, Hepatocellular 136Ovarian Neoplasms 120Multiple Myeloma 98Melanoma 95Head and Neck Neoplasms 95Esophageal Neoplasms 94Urinary Bladder Neoplasms 87Disease 87Lymphoma 79Uterine Cervical Neoplasms 78Hematologic Neoplasms 77Liver Neoplasms 76Brain Neoplasms 76Endometrial Neoplasms 73Neoplasm Metastasis 65Leukemia, Myeloid, Acute 65Colonic Neoplasms 61Rectal Neoplasms 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Leukemia 54Sarcoma 53Glioma 53

Interventions

Observation 1Independent Medical Evaluation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Observational × Pathologic Complete Response × Clear all
NCT07353840 2026-01-20

T-START-CR

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
160 enrolled
Lymphoid

Pathologic Complete Response, Lymphoma, T-Cell, Peripheral

NCT06364371 2025-12-18

Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting
106 enrolled

Pathologic Complete Response

NCT07166185 2025-09-10

NEOTRAPSCAL

Blida 1 University

Recruiting
70 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

NCT06111807 2025-03-30

MRD-LUNG

University Medical Center Groningen

Recruiting
248 enrolled
Thoracic

Pathologic Complete Response, Hypersensitivity, Lung Neoplasms, Neoplasm, Residual

NCT06182657 2024-02-08

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

Jiangxi Provincial Cancer Hospital

Recruiting
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Pathologic Complete Response

NCT03426397 2020-07-29

"Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer

The Netherlands Cancer Institute

Recruiting
220 enrolled
Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡